VanEck Associates’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,802
Closed -$21K 1409
2023
Q1
$21K Buy
1,802
+271
+18% +$3.19K ﹤0.01% 1352
2022
Q4
$18K Sell
1,531
-349
-19% -$4.53K ﹤0.01% 1366
2022
Q3
$24K Buy
+1,880
New +$23.1K ﹤0.01% 1303

Other funds holding BIOX

VanEck Associates's BIOX Position: Q2 2023 in Review

VanEck Associates sold out of Bioceres Crop Solutions (BIOX) in Q2 2023, closing a stake of 1,802 shares — an estimated $21K sold.

VanEck Associates first reported a position in BIOX in Q3 2022 and held it in 3 quarters. The position peaked at $24K in Q3 2022. 46 funds tracked by Wall St. Rank hold BIOX as of Q2 2023.

  • VanEck Associates reported no remaining Bioceres Crop Solutions position as of Q2 2023 after selling out during the quarter.
  • VanEck Associates sold 1,802 Bioceres Crop Solutions shares in Q2 2023, an estimated $21K.
  • VanEck Associates first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 3 quarters.
  • VanEck Associates's Bioceres Crop Solutions position peaked at $24K in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2023.

Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.